Recursion Pharmaceuticals: Q4 Earnings Snapshot

KIFI

Published February 27, 2023 4:51 PM

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $57.5 million in its fourth quarter.

The Salt Lake City-based company said it had a loss of 31 cents per share.

The biotechnology company posted revenue of $13.7 million in the period.

For the year, the company reported a loss of $239.5 million, or $1.36 per share. Revenue was reported as $39.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.